Two Sigma Advisers’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Two Sigma Advisers’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,300	Closed	-$200K	–	2832
2022 Q4	$200K	Buy	+16,300	New	+$388K	﹤0.01%	2191

Two Sigma Advisers's CINC Position: Q1 2023 in Review

Two Sigma Advisers sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 16,300 shares — an estimated $200K sold.

Two Sigma Advisers first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $200K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Two Sigma Advisers reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 16,300 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $200K.
Two Sigma Advisers first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Two Sigma Advisers's CinCor Pharma, Inc. Common Stock position peaked at $200K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.